Standard BioTools Inc.
Symbole: LAB
NASDAQ
2.41
USDPrix du marché aujourd'hui
-2.5738
Ratio P/E
-0.0737
Ratio PEG
923.15M
Cap MRK
- 0.00%
Rendement DIV
Standard BioTools Inc. (LAB) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 114.9 | 165.8 | 28.5 | |||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 63.2 | 84.5 | 0 | |||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 19.7 | 17.3 | 18.3 | |||||||||||||||||||
balance-sheet.row.inventory | 0 | 20.5 | 21.5 | 20.8 | |||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 3.1 | 4.3 | 4.5 | |||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 158.2 | 208.8 | 72.1 | |||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 54.9 | 59.5 | 65.2 | |||||||||||||||||||
balance-sheet.row.goodwill | 0 | 106.3 | 106.3 | 106.4 | |||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 1.4 | 12.6 | 27.9 | |||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 107.7 | 118.9 | 134.3 | |||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 0.8 | 1 | 1 | |||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | -1 | -1 | |||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 1.5 | 3.1 | 3.7 | |||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 164.9 | 181.5 | 203.1 | |||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.total-assets | 0 | 323.1 | 390.3 | 275.2 | |||||||||||||||||||
balance-sheet.row.account-payables | 0 | 9.2 | 7.9 | 10.6 | |||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 63.9 | 5.8 | 9.9 | |||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 1.2 | 1.2 | 1.4 | |||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 4 | 96.9 | 101.8 | |||||||||||||||||||
Deferred Revenue Non Current | 0 | 14.3 | 18.2 | 24.1 | |||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 20.6 | 15.3 | 13.6 | |||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 50.5 | 428.3 | 131.1 | |||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 30.4 | 37.8 | 40.6 | |||||||||||||||||||
balance-sheet.row.total-liab | 0 | 159.9 | 471.8 | 180.6 | |||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 311.3 | 311.3 | 0 | |||||||||||||||||||
balance-sheet.row.common-stock | 0 | 0.1 | 0.1 | 0.1 | |||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -1000.8 | -926.1 | -736 | |||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -2.2 | -1.9 | -0.9 | |||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 854.8 | 535.2 | 831.4 | |||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 163.2 | -81.5 | 94.6 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 323.1 | 390.3 | 275.2 | |||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.total-equity | 0 | 163.2 | -81.5 | 94.6 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||
Total Investments | 0 | 64 | 84.5 | 1 | |||||||||||||||||||
balance-sheet.row.total-debt | 0 | 98.2 | 102.7 | 111.6 | |||||||||||||||||||
balance-sheet.row.net-debt | 0 | 46.5 | 21.3 | 83.2 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -74.7 | -190.1 | -59.2 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 15.2 | 15 | 15.6 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 6.3 | 0 | 0 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 13.1 | 14.9 | 16.1 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 1.8 | -15.5 | -19.9 | |||||||||||||||||||
cash-flows.row.account-receivables | 0 | -3 | 1.1 | 6.7 | |||||||||||||||||||
cash-flows.row.inventory | 0 | -4.9 | -8.5 | -4.8 | |||||||||||||||||||
cash-flows.row.account-payables | 0 | 1.6 | -2.8 | 1.3 | |||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 8.1 | -5.3 | -23.2 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -5 | 86.3 | 3.4 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -2.8 | -3.8 | -13.3 | |||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 84.3 | 0 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -94.9 | -137.3 | 0 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 118 | 53 | 0 | |||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | -84.3 | 1.3 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 20.2 | -88.1 | -11.9 | |||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -2.1 | -6.8 | -0.5 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0.8 | 225 | 1.5 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -5.4 | -0.6 | -1.8 | |||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | -0.3 | |||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -0.1 | 13.2 | 17.1 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -6.8 | 230.8 | 16 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | -0.4 | 0 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -29.6 | 52.9 | -40.1 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 51.7 | 82.3 | 29.5 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 81.3 | 29.5 | 69.5 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -43.3 | -89.4 | -44.1 | |||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -2.8 | -3.8 | -13.3 | |||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -46.1 | -93.2 | -57.3 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 106.3 | 97.9 | 130.6 | |||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 55.9 | 60.9 | 61.2 | |||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 50.5 | 37.1 | 69.4 | |||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 7 | -12.3 | 7.6 | |||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 113.5 | 153.3 | 136.8 | |||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 169.4 | 214.2 | 198 | |||||||||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 4.3 | 0.3 | |||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 4.6 | 4.3 | 3.8 | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -11.2 | -76.7 | 3.8 | |||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 7 | -12.3 | 7.6 | |||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -11.2 | -76.7 | 3.8 | |||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 4.6 | 4.3 | 3.8 | |||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 15.2 | 2.7 | 23.2 | |||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.operating-income | 0 | -63 | -116.2 | -67.5 | |||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | -74.2 | -192.9 | -63.7 | |||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 0.5 | -2.8 | -4.4 | |||||||||||||||||||
income-statement-row.row.net-income | 0 | -74.7 | -190.1 | -59.2 |
Questions fréquemment posées
Quel est le total de Standard BioTools Inc. (LAB) de l'actif total?
Standard BioTools Inc. (LAB) Le total des actifs est 323067000.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est N/A.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est 0.472.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est -0.578.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est -0.702.
Quel est le revenu total de l'entreprise?
Le revenu total est -0.659.
Qu'est-ce que Standard BioTools Inc. (LAB) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est -74656000.000.
Quel est l'endettement total de l'entreprise?
La dette totale est 98210000.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 113489000.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 0.000.